Lancet southeastern United States? A review of unlikely Neurol ; Am J Med Sci 8. Heart disease ; Factors explaining the American Heart Association. Circulation ; excess stroke prevalence in the US stroke belt.
The global Trends in stroke burden of chronic diseases: overcoming imped- incidence, mortality and case fatality rates in iments to prevention and control. J Neurol Neurosurg Psychiatr ; Incidence of The decline in stroke stroke subtypes, prognosis and prevalence of mortality. Gorelick B, Ruland S. Cerebral vascular disease. J Neurol Neurosurg Psychiatr Disease a month ; Gorelick, B.
The future of stroke prevention by Prevalence of risk factor modification. Handbook of clinical neu- stroke and related burden among older people rology; stroke Part III, M.
Fisher, Ed. Elsevier, living in Latin America, India, China. J Neurol New York; Neurosurg Psychiatry Risk factors for is- Stroke control study. Lancet ; Hankey, J. Potential new risk factors for ischemic Rothwell M, Warlow P. Timing of transient isch- stroke. What is their potential? Stroke ; aemic attacks preceding ischaemic stroke.
Neurology ; Combining multiple Definition and eval- approaches for the secondary prevention of vas- uation of transient ischemic attack. A scientific cular events after stroke: a quantitative modeling statement for healthcare proffesionals from the study.
Stroke diovascular Surgery and Anesthesia; Council ; Sudlow L, Warlow P. Comparable studies of the Council on Cardiovascular Nursing; and the incidence of stroke and its pathological types: Interdisciplinary council on peripheral Vascular results from an international collaboration. Silent brain Stroke epide- infarcts: a systematic review. Lancet Neurol ; miology, prevention and management strategies Hemorrhagic bean. Lancet Neurol ; Aring D, Merritt, H. Differential diagnosis between features, and outcome.
A case-control study. Acta Neurol Scand ; Arch Intern Med ; Del Zoppo J. Microvascular changes during Transient ischemic cerebral ischemia and reperfusion. Cerebrovasc attack-proposal for a new definition. Med ; Neuropathology A multicenter pooled, of ischemic brain injury. En: Fisher M Editors. Volume Elsevier; Prognosis of transient ischemic attacks in the Oxfordshire Community stroke Project.
Rothwell M, Warlow P. Timing of transient isch- aemic attacks preceding ischaemic stroke. Definition and eval- uation of transient ischemic attack. Silent brain infarcts: a systematic review.
Hemorrhagic infarction: risk factors, clinical and tomographic features, and outcome. A case-control study. Acta Neurol Scand ; Del Zoppo J. Microvascular changes during cerebral ischemia and reperfusion. Cerebrovasc Brain Metab Rev ; Neuropathology of ischemic brain injury.
En: Fisher M Editors. Handbook of Clinical Neurology. Volume Madrid: Elsevier; Bogousslavsky J, Regli F. Unilateral watershed cerebral infarcts. Momjian-Mayor I, Baron C. The pathophysiology of watershed infarction in internal carotid artery disease.
Bogousslavsky J. Topographic patterns of cere- bral infarcts. Correlation with ethiology. Cerebro- vasc Dis ;1 Suppl Manual de enfer- medades vasculares cerebrales. Barcelona: Prous Science Arboix A, Rubio F. Una cadena asistencial.
Madrid: Mayo Edi- ciones ; p. Nomenclatura de las enfermedades vasculares cerebrales. Enfermedades vasculares cerebra- les. Barcelona: Prous Science; Classification of subtype of acute ischemic stroke. Definitions for use in a multi- center clinical trial. Epide miology of ischemic stroke sutypes according to TOAST criteria: incidence, recirrence, and long term survivel in ischemic stroke subtypes: a pop- ulation based study.
Incidence, case fatality rate, and prognosis of ischemic stroke subtypes in a predominantly hispano-mestizo population in Iquique, Chile Piscis project : a community based incidence study. Favorable outcome of ischemic stroke in patients pretreat- ed with statins. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials.
Meschia F, Barrett M. Intero- bserver agreement in the trial of org in acute stroke treatment classification of stroke base don retrospective medical record review. J Stroke Cerebrovasc Dis ; Classifi- cation of stroke subtypes. Cerebrovasc Dis ; Aphasia after stroke: natural history and as- sociated deficits. J Neurol Neurosurg Psychiatry ; 49 1 Aphasia during the acute phase in ischemic stroke.
Cerebrovasc Dis ; 25 4 Disabil Rehabil ; 26 23 Rehabilitation of brain damage: Brain plasticity and principles of guided recovery. Arterioscler Thromb Vasc Biol, 20 , pp. Leg strength in peripheral arterial disease: associations with disease severity and lower-extremity performance.. J Vasc Surg, 39 , pp. Intermittent claudication. Incidence in the Framingham Study.. Circulation, 41 , pp. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery..
Peripheral arterial disease detection, awareness, and treatment in primary care.. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes.. Mortality over a period of 10 years in patiens with peripheral arterial desease..
N Engl J Med, , pp. A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men a strong relationship to smoking and serum cholesterol: the Reykjavik Study..
J Clin Epidemiol, 47 , pp. Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality.. Vascular adhesion molecule-1 and markers of platelet function before and after a treatment with iloprost or a supervised physical exercise program in patients with peripheral arterial disease..
Life Sci, 69 , pp. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.. BMJ, , pp. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable Angina to Prevent Recurrent Events CURE Study.. CB Medline. F6 Medline. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease..
Eur Heart J, 25 , pp. Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double blind trial with objective assessment of chronic occlusive arterial disease patients.. Am Heart J, , pp. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease..
Circulation, 80 , pp. Does pentoxifylline prolong the walking distance in exercised claudicants? A placebo-controlled double-blind trial.. Angiology, 42 , pp. Management of intermittent claudication with pentoxifylline: Meta-analysis of randomized controlled trials.. Can Med Assoc J, , pp. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline or nafronyl: A meta-analysis..
Arch Intern Med, , pp. A new pharmacological treatment for intermittent claudication: Results of a randomized, multicenter trial.. Cilostazol has beneficial effects in treatment of intermittent claudication.. Circulation, 98 , pp. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease.. F5 Medline.
0コメント